C-MER Medical Holdings Limited (3309.HK) has a MoatMap StockRank of 71/100 based on Quality (59/100), Value (74/100), and Momentum (21/100) factor scores. The current signal is BUY. C-MER Medical operates eye clinics in Hong Kong and China. It is a localized service provider with no connection to our global macro themes.
C-MER Medical Holdings Limited provides specialty ophthalmic services, dental, and other medical services across Hong Kong and the Greater Bay Area. The company leverages its strong brand equity and clinical expertise established by founder Dr. Dennis Lam to capture premium private healthcare demand. It operates as a leading private eye care service provider with a growing network of eye hospitals and clinics.
| Price | $0.13 |
| Market Cap | $164M |
| P/E (TTM) | 13.13 |
| P/E (Forward) | 11.67 |
| Price/Book | 0.70 |
| Return on Equity | 5.8% |
| Return on Invested Capital | 7.9% |
| Debt/Equity | 22.04 |
| Gross Margin | 31.0% |
| Operating Margin | 7.6% |
| Revenue Growth | 1.2% |
| Dividend Yield | 1.8% |
| Free Cash Flow | $3M |
C-MER Medical Holdings Limited operates in the Medical Care Facilities industry, part of the Healthcare sector (Hong Kong).